Fundz

Apimeds Pharmaceuticals Appoints Eric Sherb as Chief Financial Officer

PUBLIC · APUSOct 01, 2026

Position

Chief Financial Officer

Company

Apimeds Pharmaceuticals US

Erick Frim
New JerseyBiotechnologyHealth CareTherapeuticsBiopharma

Description

On September 30, 2026, Apimeds Pharmaceuticals US, Inc. appointed Eric Sherb as Chief Financial Officer, effective October 1, 2026. This appointment follows the resignation of Erik Frim as Interim Chief Financial Officer

Company Information

Company

Apimeds Pharmaceuticals US

Location

New Jersey, United States

About

Apimeds is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered honeybee venom-based toxin. They are focused on creating potential treatments for osteoarthritis knee pain. The company aims to offer solutions for patients who don't respond adequately to standard non-pharmacologic therapies. Apimeds is dedicated to advancing innovative therapeutic options.

Fundz sees it the moment Apimeds Pharmaceuticals US changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Erik
Senior decision-maker at this company
••••••••@••••••••

See Erik's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Apimeds Pharmaceuticals US's next move

Learn about Strategic plan

Apimeds Pharmaceuticals US changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.